Back HIV Prevention Treatment as Prevention

Treatment as Prevention

AIDS 2016: More Confidence on Zero Risk -- Still No Linked HIV Infections in PARTNER Study

The PARTNER study, which 2 years ago generated headlines by establishing that the chance of an HIV-positive person with an undetectable viral load transmitting the virus was very low and quite possibly zero, released new data last week at the 21st International AIDS Conference (AIDS 2016) that further refined this estimate. The findings were also published in the July 12 New England Journal of Medicine.

alt

Read more:

AIDS 2016: SEARCH Study Exceeds 90-90-90 Targets After 2 Years of HIV Test-and-Treat

A large study that embeds "'test-and-treat" for HIV within a larger multi-disease prevention campaign in rural Kenya and Uganda has achieved 82% viral suppression after 2 years, and has already exceeded UNAIDS targets for viral suppression after 1 year of activity, investigators from the SEARCH study reported at the 21st International AIDS Conference (AIDS 2016) this week in Durban.

alt

Read more:

IAPAC Summit: How Do We Treat the World? Experts Discuss Moving to Universal HIV Treatment

What practical steps does the global healthcare community need to take in order to expand HIV treatment so that it can reach everyone who is diagnosed? And how do we expand testing so that as many HIV-positive people as possible are diagnosed, on treatment, and virally suppressed? These were the themes of the discussion concerning what used to be called "Treatment as Prevention" at the recent 2015 IAPAC Controlling the HIV Epidemic with Antiretrovirals summit in Paris.

alt

Read more:

HIV Treatment Reduces HIV Transmission by 77% among South African Couples

Antiretroviral treatment reduced the risk of HIV transmission by 77% in serodiscordant couples in rural South Africa, a population-based study carried out in the province of KwaZulu-Natal has shown. The findings were recently published in the advance online edition of Clinical Infectious Diseases. The investigators say that their findings provide a real-life estimate of the impact of antiretroviral treatment on HIV transmission under normal community conditions.

alt

Read more:

IAPAC Summit: At Least 25,000 People in the U.S. May Now Be Using PrEP

As many as 30,000 people in the U.S. may now be taking pre-exposure prophylaxis (PrEP) to prevent HIV, researchers reported at the 4th IAPAC Controlling the HIV Epidemic with Antiretrovirals summit in Paris last week. Meanwhile, as the summit also heard, European and other countries face frustrating delays in securing access to PrEP.

alt

Read more: